Abstract：
OBJECTIVE: We aimed to investigate the influence of preoperative antituberculosis chemotherapy duration on perioperative epididymectomy complications in patients with epididymal tuberculosis (ETB).
METHODS: This retrospective study examined patients with ETB between January 1, 2013, and March 31, 2023, who underwent unilateral epididymectomy at our hospital. We selected preoperative antituberculosis chemotherapy duration of 2, 4, and 8 weeks as the cutoffs for this study, to explore whether there are differences in the incidence of intraoperative and 30-day postoperative complications among the patients with different preoperative antituberculosis chemotherapy durations. Intraoperative complications were graded according to the Satava classification, and 30-day postoperative complications were defined according to the Clavien-Dindo classification. The study groups were compared using the unpaired t-test, Wilcoxon rank-sum test, Pearson\'s chi-square test, or Fisher\'s exact test, as appropriate.
RESULTS: Overall, 155 patients were included. Statistical analysis revealed that there were no significant differences in the incidence of intraoperative and 30-day postoperative complications between patients with shorter preoperative antituberculosis chemotherapy duration and those with longer preoperative antituberculosis chemotherapy duration.
CONCLUSIONS: In patients with ETB, preoperative antituberculosis chemotherapy duration did not significantly affect the incidence of perioperative complications after epididymectomy.
METHODS: This retrospective study examined patients with ETB between January 1, 2013, and March 31, 2023, who underwent unilateral epididymectomy at our hospital. We selected preoperative antituberculosis chemotherapy duration of 2, 4, and 8 weeks as the cutoffs for this study, to explore whether there are differences in the incidence of intraoperative and 30-day postoperative complications among the patients with different preoperative antituberculosis chemotherapy durations. Intraoperative complications were graded according to the Satava classification, and 30-day postoperative complications were defined according to the Clavien-Dindo classification. The study groups were compared using the unpaired t-test, Wilcoxon rank-sum test, Pearson\'s chi-square test, or Fisher\'s exact test, as appropriate.
RESULTS: Overall, 155 patients were included. Statistical analysis revealed that there were no significant differences in the incidence of intraoperative and 30-day postoperative complications between patients with shorter preoperative antituberculosis chemotherapy duration and those with longer preoperative antituberculosis chemotherapy duration.
CONCLUSIONS: In patients with ETB, preoperative antituberculosis chemotherapy duration did not significantly affect the incidence of perioperative complications after epididymectomy.
摘要：
目的：探讨术前抗结核化疗时间对附睾结核(ETB)患者围手术期附睾切除术并发症的影响。
方法：这项回顾性研究检查了2013年1月1日至2023年3月31日在我院接受单侧附睾切除术的ETB患者。我们选择术前抗结核化疗持续时间为2、4和8周作为本研究的截止时间。探讨不同术前抗结核化疗时间的患者术中、术后30d并发症发生率是否存在差异。术中并发症根据Satava分类进行分级,根据Clavien-Dindo分类定义术后30天并发症。研究组采用非配对t检验进行比较，Wilcoxon秩和检验,皮尔森卡方检验，或者费希尔的精确检验，视情况而定。
结果：总体而言，包括155名患者。统计分析表明，术前抗结核化疗持续时间较短的患者与术前抗结核化疗持续时间较长的患者，术中和术后30天并发症的发生率没有显着差异。
结论：在ETB患者中，术前抗结核化疗持续时间对附睾切除术后围手术期并发症的发生率无显著影响。
方法：这项回顾性研究检查了2013年1月1日至2023年3月31日在我院接受单侧附睾切除术的ETB患者。我们选择术前抗结核化疗持续时间为2、4和8周作为本研究的截止时间。探讨不同术前抗结核化疗时间的患者术中、术后30d并发症发生率是否存在差异。术中并发症根据Satava分类进行分级,根据Clavien-Dindo分类定义术后30天并发症。研究组采用非配对t检验进行比较，Wilcoxon秩和检验,皮尔森卡方检验，或者费希尔的精确检验，视情况而定。
结果：总体而言，包括155名患者。统计分析表明，术前抗结核化疗持续时间较短的患者与术前抗结核化疗持续时间较长的患者，术中和术后30天并发症的发生率没有显着差异。
结论：在ETB患者中，术前抗结核化疗持续时间对附睾切除术后围手术期并发症的发生率无显著影响。
